Skip to content
HowShorted

Allogene Therapeutics, Inc. short interest in 2026

In 2026, Allogene Therapeutics, Inc.'s disclosed short interest ran from 8.29% of shares outstanding on 15 Jan 2026 to 17.25% on 15 Sep 2026, a change of +8.96 percentage points. The year's high was 26.00% on 30 Jun 2026 and its low 8.29% on 15 Jan 2026, averaging 15.97% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.15 days on 31 Aug 2026. Full history: Allogene Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Allogene Therapeutics, Inc. in 2026

2026 in figures

Start of year
8.29% (15 Jan 2026)
End of year
17.25% (15 Sep 2026)
Change
+8.96 pp
High
26.00% (30 Jun 2026)
Low
8.29% (15 Jan 2026)
Average
15.97%
Highest days to cover
12.15 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Allogene Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20268.29%3.51
30 Jan 20268.37%2.59
13 Feb 20268.88%3.74
27 Feb 202610.65%3.96
13 Mar 202610.02%6.2110-K filed, results (8-K)
31 Mar 202613.15%4.81
15 Apr 202614.92%1.60
30 Apr 202615.12%3.71
15 May 202617.34%6.4110-Q filed, results (8-K)
29 May 202618.25%6.77
15 Jun 202619.70%6.21
30 Jun 202626.00%5.14
15 Jul 202624.49%6.35
31 Jul 202624.92%9.23
14 Aug 202617.06%11.9310-Q filed, results (8-K)
31 Aug 202617.11%12.15
15 Sep 202617.25%11.26

See also: Allogene Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.